Inoue Makoto, Wakai Toshifumi, Korita Pavel V, Sakata Jun, Kurosaki Ryo, Ogose Akira, Kawashima Hiroyuki, Shirai Yoshio, Ajioka Yoichi, Hatakeyama Katsuyoshi
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata 951-8510, Japan.
Oncol Lett. 2011 Mar;2(2):207-210. doi: 10.3892/ol.2011.246. Epub 2011 Jan 20.
Ewing sarcoma/primitive neuroectodermal tumors (ES/PNETs) may arise in bone or soft tissue; however, these tumors rarely originate in the stomach. To the best of our knowledge, only four cases have previously been reported in the English-language literature. A 41-year-old Japanese woman was admitted with abdominal pain and underwent gastrectomy to remove the primary tumor. Immunohistochemistry, chromosomal karyotype and molecular analysis using reverse transcription-polymerase chain reaction were performed in the tumor specimens obtained. Tumor cells showed positive immunoreactivity for CD99, vimentin, CD117 (c-kit), S100, chromogranin A and synaptophysin. The tumor was a gastric ES/PNET with the EWS-FLI1 fusion gene translocation t(11;22)(q24;q12). Multiple repeat metastasectomies, as well as multi-agent chemotherapy and radiotherapy were performed for recurrent disease. Despite treatment, the patient succumbed due to progressive disease 110 months after the initial surgery for gastric ES/PNET. A review of the reported cases suggests that patients with gastric ES/PNETs have an unfavorable prognosis following resection due to the high propensity of these tumors to metastasize. Thus, multimodal treatment approaches including surgery, as well as multi-agent chemotherapy and radiotherapy may provide a survival benefit for patients with gastric ES/PNETs.
尤因肉瘤/原始神经外胚层肿瘤(ES/PNETs)可发生于骨骼或软组织;然而,这些肿瘤很少起源于胃。据我们所知,英文文献中此前仅报道过4例。一名41岁的日本女性因腹痛入院,并接受了胃切除术以切除原发性肿瘤。对获取的肿瘤标本进行了免疫组织化学、染色体核型分析以及使用逆转录聚合酶链反应的分子分析。肿瘤细胞对CD99、波形蛋白、CD117(c-kit)、S100、嗜铬粒蛋白A和突触素呈阳性免疫反应。该肿瘤为具有EWS-FLI1融合基因易位t(11;22)(q24;q12)的胃ES/PNET。针对复发性疾病进行了多次重复转移灶切除术以及多药化疗和放疗。尽管进行了治疗,但患者在初次手术治疗胃ES/PNET后110个月因疾病进展而死亡。对已报道病例的回顾表明,胃ES/PNET患者在切除术后预后不佳,因为这些肿瘤极易发生转移。因此,包括手术以及多药化疗和放疗在内的多模式治疗方法可能会给胃ES/PNET患者带来生存益处。